Valuation: Carmat SA

Market Cap 61.46L 70.22L 56.76L 52.24L 98.41L 68Cr 1.01Cr 6.77Cr 2.66Cr 33Cr 2.64Cr 2.58Cr 114.1Cr P/E 2023
-3.09x
P/E 2024 -0.95x
Enterprise Value 5.92Cr 6.77Cr 5.47Cr 5.04Cr 9.49Cr 652.39Cr 9.71Cr 65Cr 26Cr 319.58Cr 25Cr 25Cr 1.1TCr EV / Sales 2023
56.1x
EV / Sales 2024 13.5x
Free-Float
89.06%
Yield 2023 *
-
Yield 2024 -
Current year 0.1
Extreme 0.099
0.1
1 year 0.08
Extreme 0.085
0.59
3 years 0.08
Extreme 0.085
9.99
5 years 0.08
Extreme 0.085
31.7
10 years 0.08
Extreme 0.085
44.95
Manager TitleAgeSince
Chief Executive Officer 55 01/09/2016
Director of Finance/CFO - 12/12/2018
Chief Tech/Sci/R&D Officer - 01/04/2025
Director TitleAgeSince
Director/Board Member 55 -
Director/Board Member 68 02/01/2017
Director/Board Member 79 20/04/2017
Date Insider Type Main position Quantity % Market Cap.
13/03/25 Buy

Chairman

13,43,333 2.3347%
13/03/25 Sell

Chairman

13,43,333 2.3347%
29/05/24 Buy

Director

13,43,333 4.6122%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-70.71%-98.72% 70.8L
-3.42%-3.01%-17.86%+7.83% 12TCr
-1.03%+0.96%+2.31%-2.04% 1.3TCr
+0.93%+2.69%+60.52%+99.12% 920.68Cr
+3.09%+12.41%-43.39%-68.31% 447.15Cr
-6.27%-0.13%+5.35%+45.65% 269.57Cr
-6.41%-7.36%-22.63%-31.72% 161.68Cr
-4.80%-0.43%-12.90%-21.55% 159.88Cr
-3.56%+5.13%+2.97%-58.53% 155.82Cr
Average -2.39%+2.02%-10.70%-14.25% 1.74TCr
Weighted average by Cap. -2.88%-1.66%-11.70%+9.48%

Financials

2023 2024
Net sales 38.37L 43.84L 35.44L 32.61L 61.44L 42Cr 62.87L 4.23Cr 1.66Cr 21Cr 1.65Cr 1.61Cr 71Cr 73.44L 83.91L 67.82L 62.42L 1.18Cr 81Cr 1.2Cr 8.09Cr 3.18Cr 40Cr 3.15Cr 3.08Cr 136.35Cr
Net income -5.39Cr -6.15Cr -4.97Cr -4.58Cr -8.63Cr -593.18Cr -8.83Cr -59Cr -23Cr -290.58Cr -23Cr -23Cr -1TCr -5.14Cr -5.87Cr -4.75Cr -4.37Cr -8.23Cr -565.94Cr -8.42Cr -57Cr -22Cr -277.23Cr -22Cr -22Cr -954.21Cr
Net Debt 4.96Cr 5.67Cr 4.58Cr 4.22Cr 7.95Cr 546.57Cr 8.13Cr 55Cr 22Cr 267.75Cr 21Cr 21Cr 921.55Cr 5.31Cr 6.07Cr 4.9Cr 4.51Cr 8.5Cr 584.71Cr 8.7Cr 59Cr 23Cr 286.43Cr 23Cr 22Cr 985.87Cr
Logo Carmat SA
Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.
Employees
153
  1. Stock Market
  2. Stocks
  3. ALCAR Stock